MERGE

MERGE sources deal flow primarily through its agency-client relationships. By working deeply with pharmaceutical, CPG, and retail companies on brand and digital strategy, the firm identifies operational pain points and emerging consumer behaviors that inform its venture thesis. This client-embedded model provides access to early-stage opportunities that are not broadly shopped through traditional venture networks.

MERGE does not publicly disclose the structure of its investment capital. The firm's model suggests it uses professional-services revenue to fund equity positions, operating more like a self-capitalized venture studio than a traditional GP. There is no public record of MERGE raising a dedicated venture fund from limited partners.

Specific investment decision-makers at MERGE are not publicly named. The firm's leadership has not published a dedicated investment committee roster separate from its agency executive team, and no single venture-partner title is disclosed in available records.

MERGE concentrates on digital health, consumer technology, and enterprise marketing software. The health vertical, including clinical-trial recruitment and patient-engagement platforms, has surfaced in its recent partnership activity. Consumer direct-to-consumer wellness brands also align with its agency's pharmaceutical and CPG client base.

MERGE is an asset manager structured as a hybrid professional-services firm and venture studio. There is no indication it functions as a single-family office. It does not manage a disclosed pool of family capital and has not published any multi-family office or wealth-management offerings.